Douglas Berger Psychiatrist Tokyo – About Dr. Douglas Berger

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center

Douglas Berger, M.D., Ph.D., a fully bilingual American board certified psychiatrist, is the Director of the Tokyo Meguro Counseling Center. Dr. Doug Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry. He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. See what we write about on Twitter: Dr. Berger’s Twitter Page Meguro Counseling Center Twitter Page.

Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

For more information on Dr. Doug Berger, read some of the articles here.

To contact Douglas Berger psychiatrist Tokyo please click here

If one is used to taking certain meds they may not want to make any changes. People get attached to a certain make, certain doses, immediate vs. delayed release, etc. Sometimes there is an actual reason to keep the regimen, sometimes changing is just a "nocebo" effect.

Is polypharmacy ok or not? Fewer drugs are better of course, but while polypharm regimen A may cause troubles, polypharm regimen B may work well.

Patient, "Is this drug effective?", Dr, "Clinical trials show efficacy in persons with problems similar to yours, but THERE IS NO DATA ABOUT YOU, so we need to carefully look at this as treatment progresses". #clinicaltrials #Psychiatry

What are “irreversible passage points”? If you wait the passage is irreversible: waiting too long for marriage or family making, waiting to study something and then getting old, a family dies with your plans still hanging, etc. Look closely at the train you are on and the stops!

The dose-response issue keeps popping up. This time it's depot injections. "I don't have symptoms so I often skip my injection days" is common. This defeats the purpose of getting depot injections to begin with.

Load More...

“Do you feel ill or not ill?”, “Do you want the full treatment or not?” We try to see clearly what people need and go from there. Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg

What’s the answer to finding the right therapist? The one who tells you, “We have to find out what will work by some trial and error”. Not the one who says “This is what to do”. Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg

Many persons with a history of depression, even suicidality, continue to have lingering symptoms many years later. The problem is that they don’t want to believe it’s them, they want to blame their environment. Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg #depression

What about paranoia? We can give meds but what about reasoning? An “agency coming after me” is common. We try to remind people that if an agency was after them they would have been gotten already because agencies don’t like to waste time. Us: https://t.co/W6SS4mUflN

What to do when your company wants you to get a specific psychiatric intervention to return back to work, although you don’t have a problem to work? Get a Dr letter and a legal consultation. Us: https://t.co/W6SS4mCEuf, https://t.co/urVpIy8ewg

Load More...